Previous symbols: FACA, FANCH. Aliases: FAA, FA-H, FAH.
FANCA is one of the Fanconi anemia (FA) proteins and an essential structural subunit of the multiprotein FA core complex (also called the Fanconi anaemia nuclear complex), which is composed of FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL/PHF9 and FANCM together with associated FAAP proteins (FAAP20, FAAP24, FAAP100). The FA core complex is a nuclear multisubunit E3 ubiquitin ligase (with FANCL as the catalytic RING subunit and UBE2T/FANCT as the E2) that, in response to DNA interstrand crosslinks encountered during replication, monoubiquitinates the FANCD2-FANCI (ID2) heterodimer. Monoubiquitinated ID2 is loaded onto chromatin and coordinates downstream nucleolytic incision, translesion synthesis and homologous-recombination repair of the crosslink. FANCA is not the catalytic subunit; it is a large, predominantly alpha-helical scaffolding and protein-interaction hub that binds FANCG and FANCF and directly anchors FAAP20, and it is required for the assembly, stability, nuclear accumulation and chromatin loading of the core complex. The functional form of FANCA is nuclear (a minor pool is cytoplasmic), and its nuclear accumulation depends on FANCC binding and phosphorylation. Biallelic loss-of-function mutations in FANCA are the most common cause of Fanconi anemia (complementation group A, ~60-65% of cases), a chromosomal-instability syndrome with bone-marrow failure, congenital malformations, cellular hypersensitivity to DNA crosslinking agents, and cancer predisposition.
Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.
| Disorder | Relationship | Where the gene appears |
|---|---|---|
| Fanconi_Anemia |
untyped
Pathogenic Variants
|
mechanism: Core Complex Dysfunction
subtype: FA-A
phenotype: Increased Risk of Leukemia
|
| Inherited Aplastic Anemia |
untyped
Most common FA complementation group, accounting for 60-70% of cases
germline
|
scoped to subtype: Fanconi Anemia
|
An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.
| ClinGen disease | MOI | Classification | dismech entry |
|---|---|---|---|
| Fanconi anemia complementation group A MONDO:0009215 | AR | Definitive 2019-04-19 |
Fanconi_Anemia
untyped
|
Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.